购物车
- 全部删除
- 您的购物车当前为空
CYM-5541 (ML249) 是一种选择性的S1P3受体变构激动剂,EC50值在72至132 nM 之间。
为众多的药物研发团队赋能,
让新药发现更简单!
CYM-5541 (ML249) 是一种选择性的S1P3受体变构激动剂,EC50值在72至132 nM 之间。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 247 | 现货 | |
5 mg | ¥ 596 | 现货 | |
10 mg | ¥ 893 | 现货 | |
25 mg | ¥ 1,790 | 现货 | |
50 mg | ¥ 2,680 | 现货 | |
100 mg | ¥ 3,950 | 现货 | |
500 mg | ¥ 8,550 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 655 | 现货 |
产品描述 | CYM-5541 (ML249) is a selective and allosteric S1P3 receptor agonist. |
靶点活性 | S1P3:72-132 nM(EC50) |
体外活性 | CYM-5541是一种全效激动剂,能够达到S1P观察到的ERK磷酸化的最大水平。CYM-5541的EC50介于72和132 nM之间,并且展现出对其他S1P受体亚型的极高选择性:S1P1 EC50>10 μM,S1P2 EC50>50 μM,S1P4 EC50>50 μM,以及S1P5 EC50>25 μM。CYM-5541还在对55种GPCRs、离子通道和转运蛋白的Ricerca分析板中表现出对一大组蛋白靶点的选择性,没有显著的活动。CYM-5541使我们能够识别一个异构位点,在该位点中F263是其亲和力和效力的关键守门氨基酸。这个新颖的异构疏水口袋可能解释了CYM-5541对S1P3的选择性[1]。 |
激酶实验 | Jump-In TI CHO-K cells stably expressing WT or mutant S1P3 are serum-starved for 4 hrs. They are then incubated at 4 °C for 30 min in the binding buffer containing 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 15 mM NaF, 0.5 mM EDTA, 1 mM Na3VO4, 0.5% fatty acid-free bovine serum albumin, and protease inhibitor mixture with 0.1 nM [33P]S1P and increasing concentrations of S1P, SPM-242, or CYM-5541. Cells are washed three times with cold binding buffer. Cell-bound radioactivity is measured by lysing the cells with 0.5% SDS followed by liquid scintillation counting. The raw data is normalized so that the level of [33P]S1P bound to each cell line (WT or mutant) in the absence of competing ligand is referenced as 100% for its own cell line[1]. |
别名 | ML249, CYM 5541, CID-17253208 |
分子量 | 316.44 |
分子式 | C19H28N2O2 |
CAS No. | 945128-26-7 |
Smiles | O=C(N(C1CCCCC1)C1CCCCC1)c1cc(on1)C1CC1 |
密度 | 1.14 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (158.01 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容